Search research articles
Contact Us
Filters
Showing results (91-100 of 170) with videos related to
Page
of 17
Sort By:
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
Haematologica
|
December 11, 2025
Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response
Andrej Besse, Marianne Kraus, Tiberiu Totu, et al.
Blood
|
November 17, 2023
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy
Johannes Duell, Alexander M Leipold, Silke Appenzeller, et al.
Oncotarget
|
April 22, 2017
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma
Caleb K Stein, Charlotte Pawlyn, Shweta Chavan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Johannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Iscience
|
September 2, 2025
Carfilzomib-specific proteasome β5/β2 inhibition drives cardiotoxicity via remodeling of protein homeostasis and the renin-angiotensin-system
Max Mendez-Lopez, Andrej Besse, Christian Zuppinger, et al.
Cancers
|
April 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis
Grzegorz Charliński, Maximilian Steinhardt, Leo Rasche, et al.
Haematologica
|
March 24, 2018
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
Faith E Davies, Adam Rosenthal, Leo Rasche, et al.
Leukemia
|
January 31, 2023
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma
Alexander M Leipold, Rudolf A Werner, Johannes Düll, et al.
Theranostics
|
August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?
Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 170) with videos related to
Sort By:
Page
of 17
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
Haematologica
|
December 11, 2025
Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response
Andrej Besse, Marianne Kraus, Tiberiu Totu, et al.
Blood
|
November 17, 2023
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy
Johannes Duell, Alexander M Leipold, Silke Appenzeller, et al.
Oncotarget
|
April 22, 2017
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma
Caleb K Stein, Charlotte Pawlyn, Shweta Chavan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Johannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Iscience
|
September 2, 2025
Carfilzomib-specific proteasome β5/β2 inhibition drives cardiotoxicity via remodeling of protein homeostasis and the renin-angiotensin-system
Max Mendez-Lopez, Andrej Besse, Christian Zuppinger, et al.
Cancers
|
April 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis
Grzegorz Charliński, Maximilian Steinhardt, Leo Rasche, et al.
Haematologica
|
March 24, 2018
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
Faith E Davies, Adam Rosenthal, Leo Rasche, et al.
Leukemia
|
January 31, 2023
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma
Alexander M Leipold, Rudolf A Werner, Johannes Düll, et al.
Theranostics
|
August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?
Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Page
of 17